Results
Senores Pharmaceuticals FY26 Consolidated Net Profit ₹121.53 Crores
Senores Pharmaceuticals reported audited FY26 consolidated net profit of ₹121.53 crores with revenue from operations at ₹401.70 crores, showing strong annual growth.
The Board approved the resignation
